Biologically active fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles

Blood

Volumn 91, Issue 10, 1998, Pages 3862-3874

  Albanese, Joseph ^b   Meterissian, Sarkis ^b   Kontogiannea, Maria ^b   Dubreuil, Catherine ^b   Hand, Arthur ^b   Sorba, Sandra ^b   Dainiak, Nicholas ^a  

^a BRIDGEPORT HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL;

EID: 0032525252     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3862.3862_3862_3874     Document Type: Article

References (68)

1. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
2. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149:1366, 1992
3. Itoh N, Yonehara S, Isheii A, Yonehara M, Mizuathima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
4. Matsumoto K, Schleimer RP, Saito H, Ikura Y, Bochner BS: Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437, 1995
5. Yonehara S, Ishii A, Yonehara M: A cell killing monoclonal (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
6. Suda T, Nagata S: Purification and characterization of the Fas ligand that induces apoptosis. J Exp Med 179:873, 1994
7. Owen-Schaub LB, Meterissian S, Ford RJ: Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. Immunotherapy 14:234, 1994
8. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin JP, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and neoplastic cells. Lab Invest 69:415, 1993
9. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
10. Suda T, Nagata S: Purification and characterization of the Fas ligand that induces apoptosis. J Exp Med 179:873, 1994
11. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574, 1996
12. Smith AS, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 76:959, 1994
13. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075, 1996
14. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-A mechanism of immune evasion? Nat Med 2:1361, 1996
15. Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J-C, Tschopp J: Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 74:1363, 1996
16. Nagata S: Fas ligand and immune evasion. Nat Med 2:1306, 1996
17. Hahne M, Peitsch MC, Irrnler M, Schröter M, Lowin B, Rousseau M, Bron C, Renno T, Franch L, Tschopp J: Characterization of the non-functional Fas ligand of mice. Int Immunol 7:1381, 1995
18. Peitsch MC, Tschopp J: Comparative molecular medelling of the Fas-ligand and of the members of the TNF family. Mol Immunol 32:761, 1995
19. Midis GP, Shen Y, Owen-Schaub LB: Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res 56:3870, 1996
20. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH: Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85:1562, 1995
21. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Keifer MC, Barr PJ, Mountz JD: Protection from fas-mediated apoptosis by a soluble form of the fas molecule. Science 263:1759, 1994
22. Owen-Schaub L, Angelo LS, Radinsky R, Ware CF, Gesner TG, Bartos DP: Soluble Fas/APO-1 in tumor cells: A potential regulator of apoptosis? Cancer Lett 94:1, 1995
23. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 2:317, 1996
24. Dainiak N: Surface membrane-associated regulation of cell assembly, differentiation and growth. Blood 78:264, 1991
25. Dainiak N, Albanese J: Effects of radiation on the plasma membrane and expression of membrane bound hematopoietic cytokines, in Zander AR, Ostertag W, Afanasiev BV, Grosveld F (eds): Gene Technology: Stem Cell and Leukemia Research. NATO ASI Series. Springer, NY, 1996, p 405
26. Taylor DD, Black PH: Inhibition of macrophage Ia antigens expression by shed plasma membrane vesicles from metastatic murine melanoma cells. J Natl Cancer Inst 74:859, 1985
27. Poutsiaka DD, Schroder EW, Taylor DD, Levy EM, Black PH: Inhibition of recombinant interferon-γ-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles. J Immunol 134:145, 1985
28. Poutsiaka DD, Schroder EW, Taylor DD, Levy EM, Black PH: Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophage. J Immunol 134:138, 1985
29. 3H-thymidine incorporation are neutralized by anti TGF-β antibodies. J Submicrosc Cytol Pathol 27:535, 1995
30. Meterissian S, Toth HCA, Steele GJR, Thomas P: Kupffer cell/tumor cell interactions and hepatic metastasis in colorectal cancer. Cancer Lett 81:5, 1994
31. Dainiak N, Sorba S: Intracellular regulation of the production and release of human erythroid-directed lymphokines. J Clin Invest 87:213, 1991
32. Guha A, Dainiak, N, Freedman M, Goldschneider I, Cone RE: Regulatory effects of interferon-γ- and phorbol esters on the surface expression and biosynthesis of MHC class I antigens by human leukemia cells. Cell Immunol 151:404, 1993
33. Fellenberg J, Mau H, Scheuerpflug C, Ewerbeck V, Debatin K-M: Modulation of resistance to anti-APO-1-induced apoptosis in Osteosarcoma cells by cytokines. Int J Cancer 72:536, 1997
34. Cascino I, Fiucci G, Papoff G, Ruberti G: Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706, 1995
35. Papoff G, Cascino I, Eramo A, Strarace G, Lynch DH, Ruberti G: An N-terminal domain shared by Fas/APO-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622, 1996
36. Meterissian S, Kontogiannea M: Fas antigen expression and function in human colorectal carcinoma. Correlation with bcl-2 expression. Proc Am Assoc Cancer Res 73:104A, 1996
37. Emerson SG, Cone RE: IKk and H-2Kk antigens are shed as supramolecular particles in association with membrane lipids. J Immunol 127:482, 1981
38. Dainiak N, Cohen CM: Surface membrane vesicles from mononuclear cells stimulate erythroid stem cells to proliferate in culture. Blood 60:583, 1982
39. Feldman LC, Cohen M, Riordan MA, Dainiak N: Purification of a membrane-derived human erythroid growth factor. Proc Natl Acad Sci USA 84:6775, 1987
40. Johnstone RM, Bianchini A, Teng K: Reticulocyte maturation and exosome release: Transferrin containing exosomes show multiple plasma membrane functions. Blood 74:1844, 1989
41. Harnblin AS: Cytokines, in Male D (ed): Focus: Cytokines and Cytokine Receptors (ed 2). London, UK, IRL, 1993, p 1
42. Massagué J, Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 62:515, 1993
43. Grey PW, Aggarwal BB, Benton CV, Bringman TS, Henzel WJ, Jarrett JA, Leung DW, Moffat B, Ng P, Svedersky LP, Palladino MA, Nedwin GE: Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 312:721, 1984
44. Peters PJ, Gauze HJ, Van der Dank HA, Boast J: A new model for lethal hit delivery by cytotoxic T lymphocytes. Immunol Today 11:28, 1990
45. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanism of T cell-mediated cytotoxicity. Science 265:528, 1994
46. Armstrong MJ, Storch J, Dainiak N: Structurally distinct plasma membrane regions give rise to extracellular membrane vesicles in normal and transformed lymphocytes. Biochem Biophys Acta 688:495, 1988
47. Dainiak N: Lymphocyte surface molecules alter hematopoietic progenitor cell growth, in Paukovits WR (ed): Growth Regulation and Carcinogenesis. Boca Raton, FL, CRC, 1991, p 57
48. Tuck DD, Cerretti P, Hand A, Guha A, Sorba S, Dainiak N: Human M-CSF is expressed at and shed from the cell surface. Blood 84:2182, 1994
49. Albanese J, Dainiak N: Early plasma membrane events occurring in ultraviolet-B-induced apoptosis. Stem Cells 15:49, 1997 (suppl)
50. Kerr JFR, Harmon BV: Definition and incidence of apoptosis: A historical perspective, in Tomei LD, Cope FO (eds): Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1978, p 7
51. Kim J, Lee G-S, Tisher CC, Madsen KM: Role of apoptosis in development of the ascending thin limb of the loop of Henle in rat kidney. Am J Physiol 271:F831, 1996
52. Dainiak N, Riordan MA, Strauss PR, Feldman L, Kreczko S: Contractile proteins participate in release of erythroid growth regulators from mononuclear cells. Blood 72:165, 1988
53. Braz D, Gopplet M, Szamel M, Schirrrmacher V, Resch K: Characterization of cellular and extracellular plasma membrane vesicles from non-metastasizing lymphoma (Eb) and its metastasizing variant. Biochim Biophys Acta 814:77, 1985
54. Raz A, Geiger B: Altered organization of cell substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res 42:5183, 1982
55. Pontremoli S, Melloni E, Eppedorf: Extralysosomal protein degradation. Annu Rev Biochem 55:455, 1986
56. Fox JEB, Anstin DC, Reynolds CC, Steffen PK: Evidence that agonist-induced activation of calpain caused the shedding of procoaggulant-containing microvesicles from the surface membrane of aggregating platelets. J Biol Chem 266:13289, 1991
57. Taylor DD, Black PH: Shedding of plasma membrane fragments; neoplastic and developmental importance, in Steinberg MD (ed): The Cell Surface in Development and Cancer. New York, NY, Plenum, 1986, p 33
58. Pan B, Teng TK, Wu C, Adam M, Johnstone RM: Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 101:942, 1985
59. Caraux J, Serrou B: Release of an Fc-binding component from normal or activated lymphocytes. Ann NY Acad Sci 332:101, 1979
60. Cone RE, Marcchalonis JJ, Rolley RT: Lymphocyte membrane dynamics. Metabolic release of cell surface proteins. J Exp Med 134:1373, 1971
61. Dolo V, Adobati E, Canevari S, Picone MA, Vittorelli ML: Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13:277, 1995
62. Raz A, Geiger B: Altered organization of cell substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res 42:5183, 1982
63. Braz D, Goppelet M, Szamel M, Schirrmacher V, Resch K: Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant. Biochim Biopys Acta 814:77, 1985
64. Hughes DP, Crispe NI: A naturally occurring soluble isoform of murine fas generated by alternative splicing. J Exp Med 182:1395, 1995
65. Raz A, Goldman R, Yuli I, Inbar M: Isolation of plasma membrane fragments and vesicles from ascites fluid of lymphoma-bearing mice and their possible role in the escape mechanism of tumors from host immune rejection. Cancer Immunol Immunother 4:53, 1978
66. Koch GLE, Smith MJ: An association between actin and the major histo-compatibility antigen H-2. Nature 270:273, 1978
67. Dainiak N, Cohen CM: Regulation of human erythroid proliferation in vitro by leukocyte surface components. Ann NY Acad Sci 459:129, 1985
68. Sato K, Kimura F, Nakamura Y, Murakami H, Yoshida M, Tanaka M, Nagata S, Kanatani Y, Wakimoto N, Nagata N, Motoyshi K: An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. Br J Haematol 94:379, 1996